InVivo Biosystems

Private

Eugene, OregonHealthcare & Life Scienceshttps://invivobiosystems.com/

Last Round

VC Round

Jan 3, 2024

Total Funding Raised

$8.59M

Company Overview

InVivo Biosystems is a biotechnology company that provides a genome editing platform and preclinical services using C. elegans and zebrafish models to accelerate drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

contract research organizationCROgenome editingCRISPR gene editingzebrafish modelsC. elegans modelspreclinical researchin vivo modelsdrug discovery serviceshumanized animal modelsanimal modelshigh-throughput screeningphenotyping servicesdisease modelsmultiplexed CRISPRautomated phenotyping

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InVivo Biosystems Comparables

Compare InVivo Biosystems with similar companies based on industry and business-model similarity.

InVivo Biosystems comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

InVivo Biosystems Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jan 3, 2024
Grant	Dec 7, 2023
Grant	Apr 24, 2020
Series A	Jul 29, 2019
Grant	Jan 28, 2014

View all Funding Rounds

Key People

Founding team and executive leadership

Shawn Lockery

Co-founder & CTO

Founding Team

Kat McCormick

Chief Executive Officer

Executive Team

Anthony Iverson

Chief Financial Officer

Executive Team

InVivo Biosystems Investors

Notable investors and investment history

InVivo Biosystems investors
Investor	Rounds
Oregon Venture Fund	Series A
NIH RADx	Grant
ONAMI	VC Round
Portland Seed Fund	VC Round
Rogue Venture Partners	Series A, VC Round
Oregon Nanoscience and Microtechnologies Institute	Grant
Launch Oregon	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 7, 2026
Monthly visitors increased 45% MoM.
May 1, 2025
Monthly visitors increased 91% MoM, reaching 8.8K.

View all signals

InVivo Biosystems Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

InVivo Biosystems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about InVivo Biosystems's valuation, stock price, and market status.

Firmographic Details

HeadquartersEugene, Oregon

Employee Range43

Year Founded2011

Last FundingJan 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.